Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

July 2017

Specialty Pharmacy Program Updates


Harvard Pilgrim’s Specialty Pharmacy Program has added the following medications:

Name Indication Coverage Available From

Austedo (deutetrabenazine) 

Indicated for the treatment of chorea associated with Huntington’s disease.  Pharmacy  Limited Distribution Drug:  Cardinal Health Specialty Pharmacy

Emflaza (deflazacort)

A corticosteroid indicated for the treatment of Duchenne
muscular dystrophy (DMD) in patients 5 years of age and older.

Pharmacy Limited Distribution Drug:  U.S. Bioservices

To request prior authorization for Austedo or Emflaza, providers in Massachusetts should use the Massachusetts Standard Form for Medication Prior Authorization Requests. Providers in all other states should use the drug-specific Medication Request Forms, which are located in the “Pharmacy” section of our Provider website, along with the clinical coverage criteria. Completed forms should be faxed to MedImpact Healthcare Systems at 858-790-7100.

Email this article to a colleague   


Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Webinars for New Sleep Diagnostic and Sleep Therapy Program

Eric Schultz Signs on for CEOs Against Stigma

CLINICIAN CORNER

Updates to Medical Policies

CVS Health–NovoLogix: Prior Authorization for Overlapping Medical/Pharmacy Drugs

Benefits of Medication Therapy Management Program

P&T Committee Updates

Specialty Pharmacy Program Updates

OFFICE ASSISTANT

ACA Risk Adjustment Data Validation: Medical Chart Requests Underway

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Vice President, Network Services

Annmarie Dadoly,
Editor

Joseph O'Riordan,
Writer

Kristin Edmonston,
Production Coordinator